Gilead Sciences, Inc. (GILD)
USD 90.69
(-2.27%)
USD 90.69
(-2.27%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 24.98 Billion USD | -0.96% |
| 2022 | 25.23 Billion USD | -5.49% |
| 2021 | 26.69 Billion USD | -14.99% |
| 2020 | 31.4 Billion USD | 27.69% |
| 2019 | 24.59 Billion USD | -9.99% |
| 2018 | 27.32 Billion USD | -18.54% |
| 2017 | 33.54 Billion USD | 27.31% |
| 2016 | 26.34 Billion USD | 1317200.0% |
| 2015 | 2 Million USD | -86.67% |
| 2014 | 15 Million USD | -76.5% |
| 2013 | 63.83 Million USD | -99.22% |
| 2012 | 8.22 Billion USD | 8.11% |
| 2011 | 7.6 Billion USD | 111.79% |
| 2010 | 3.59 Billion USD | 187.72% |
| 2009 | 1.24 Billion USD | -8.34% |
| 2008 | 1.36 Billion USD | 3.83% |
| 2007 | 1.31 Billion USD | -7.0% |
| 2006 | 1.41 Billion USD | 368.86% |
| 2005 | 300.85 Million USD | 72395.42% |
| 2004 | 415 Thousand USD | -99.88% |
| 2003 | 345.46 Million USD | -41.98% |
| 2002 | 595.46 Million USD | 136.41% |
| 2001 | 251.88 Million USD | -1.33% |
| 2000 | 255.27 Million USD | 190.08% |
| 1999 | 88 Million USD | 6185.71% |
| 1998 | 1.4 Million USD | -56.25% |
| 1997 | 3.2 Million USD | -50.77% |
| 1996 | 6.5 Million USD | 1.56% |
| 1995 | 6.4 Million USD | 77.78% |
| 1994 | 3.6 Million USD | 0.0% |
| 1992 | 1.8 Million USD | 80.0% |
| 1991 | 1 Million USD | 25.0% |
| 1990 | 800 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 25.19 Billion USD | 0.83% |
| 2024 Q2 | 23.35 Billion USD | -7.32% |
| 2023 FY | 24.98 Billion USD | -0.96% |
| 2023 Q1 | 26.51 Billion USD | 5.1% |
| 2023 Q3 | 25.9 Billion USD | -2.61% |
| 2023 Q2 | 26.6 Billion USD | 0.32% |
| 2023 Q4 | 24.98 Billion USD | -3.55% |
| 2022 Q1 | 26.2 Billion USD | -1.82% |
| 2022 Q3 | 25.22 Billion USD | -3.79% |
| 2022 FY | 25.23 Billion USD | -5.49% |
| 2022 Q2 | 26.21 Billion USD | 0.03% |
| 2022 Q4 | 25.23 Billion USD | 0.03% |
| 2021 Q1 | 30.16 Billion USD | -3.94% |
| 2021 Q2 | 30.17 Billion USD | 0.03% |
| 2021 Q3 | 27.68 Billion USD | -8.25% |
| 2021 Q4 | 26.69 Billion USD | -3.58% |
| 2021 FY | 26.69 Billion USD | -14.99% |
| 2020 Q3 | 29.29 Billion USD | 21.53% |
| 2020 Q2 | 24.1 Billion USD | 0.02% |
| 2020 FY | 31.4 Billion USD | 27.69% |
| 2020 Q1 | 24.09 Billion USD | -2.02% |
| 2020 Q4 | 31.4 Billion USD | 7.21% |
| 2019 Q1 | 26.57 Billion USD | -2.72% |
| 2019 Q3 | 24.58 Billion USD | -5.73% |
| 2019 Q2 | 26.08 Billion USD | -1.86% |
| 2019 FY | 24.59 Billion USD | -9.99% |
| 2019 Q4 | 24.59 Billion USD | 0.02% |
| 2018 Q3 | 27.31 Billion USD | -6.0% |
| 2018 Q2 | 29.06 Billion USD | 0.02% |
| 2018 Q4 | 27.32 Billion USD | 0.02% |
| 2018 Q1 | 29.05 Billion USD | -13.38% |
| 2018 FY | 27.32 Billion USD | -18.54% |
| 2017 FY | 33.54 Billion USD | 27.31% |
| 2017 Q4 | 33.54 Billion USD | 14.63% |
| 2017 Q3 | 29.26 Billion USD | 11.28% |
| 2017 Q2 | 26.29 Billion USD | -0.09% |
| 2017 Q1 | 26.32 Billion USD | -0.09% |
| 2016 Q3 | 27.07 Billion USD | 22.34% |
| 2016 Q1 | 22.82 Billion USD | 1141000.0% |
| 2016 Q2 | 22.12 Billion USD | -3.05% |
| 2016 Q4 | 26.34 Billion USD | -2.68% |
| 2016 FY | 26.34 Billion USD | 1317200.0% |
| 2015 Q2 | 7 Million USD | -36.36% |
| 2015 Q4 | 2 Million USD | -50.0% |
| 2015 FY | 2 Million USD | -86.67% |
| 2015 Q3 | 4 Million USD | -42.86% |
| 2015 Q1 | 11 Million USD | -26.67% |
| 2014 Q4 | 15 Million USD | -45.22% |
| 2014 Q3 | 27.38 Million USD | -23.67% |
| 2014 Q2 | 35.87 Million USD | -21.61% |
| 2014 FY | 15 Million USD | -76.5% |
| 2014 Q1 | 45.76 Million USD | -28.3% |
| 2013 Q4 | 63.83 Million USD | -99.13% |
| 2013 Q3 | 7.31 Billion USD | -0.33% |
| 2013 FY | 63.83 Million USD | -99.22% |
| 2013 Q1 | 7.99 Billion USD | -2.75% |
| 2013 Q2 | 7.33 Billion USD | -8.25% |
| 2012 Q2 | 9.09 Billion USD | -3.5% |
| 2012 FY | 8.22 Billion USD | 8.11% |
| 2012 Q4 | 8.22 Billion USD | -6.24% |
| 2012 Q3 | 8.77 Billion USD | -3.6% |
| 2012 Q1 | 9.42 Billion USD | 23.94% |
| 2011 FY | 7.6 Billion USD | 111.79% |
| 2011 Q4 | 7.6 Billion USD | 95.39% |
| 2011 Q3 | 3.89 Billion USD | 0.39% |
| 2011 Q2 | 3.87 Billion USD | -13.88% |
| 2011 Q1 | 4.5 Billion USD | 25.37% |
| 2010 Q4 | 3.59 Billion USD | 4.08% |
| 2010 Q1 | 1.24 Billion USD | -0.35% |
| 2010 FY | 3.59 Billion USD | 187.72% |
| 2010 Q2 | 1.75 Billion USD | 40.89% |
| 2010 Q3 | 3.45 Billion USD | 96.91% |
| 2009 Q3 | 1.41 Billion USD | -11.46% |
| 2009 Q1 | 1.17 Billion USD | -13.8% |
| 2009 Q4 | 1.24 Billion USD | -11.73% |
| 2009 FY | 1.24 Billion USD | -8.34% |
| 2009 Q2 | 1.59 Billion USD | 36.05% |
| 2008 Q2 | 1.33 Billion USD | 1.5% |
| 2008 Q1 | 1.31 Billion USD | -0.11% |
| 2008 Q4 | 1.36 Billion USD | 2.62% |
| 2008 Q3 | 1.32 Billion USD | -0.21% |
| 2008 FY | 1.36 Billion USD | 3.83% |
| 2007 FY | 1.31 Billion USD | -7.0% |
| 2007 Q3 | 1.41 Billion USD | 0.83% |
| 2007 Q1 | 1.39 Billion USD | -1.02% |
| 2007 Q2 | 1.4 Billion USD | 0.81% |
| 2007 Q4 | 1.31 Billion USD | -7.57% |
| 2006 Q3 | 1.44 Billion USD | -3.94% |
| 2006 Q2 | 1.49 Billion USD | 512.72% |
| 2006 Q4 | 1.41 Billion USD | -2.08% |
| 2006 Q1 | 244.75 Million USD | -18.65% |
| 2006 FY | 1.41 Billion USD | 368.86% |
| 2005 FY | 300.85 Million USD | 72395.42% |
| 2005 Q4 | 300.85 Million USD | 73458.92% |
| 2005 Q3 | 409 Thousand USD | -5.76% |
| 2005 Q2 | 434 Thousand USD | 3.33% |
| 2005 Q1 | 420 Thousand USD | 1.2% |
| 2004 Q3 | 345.29 Million USD | -0.0% |
| 2004 Q2 | 345.3 Million USD | -0.01% |
| 2004 Q1 | 345.33 Million USD | -0.04% |
| 2004 FY | 415 Thousand USD | -99.88% |
| 2004 Q4 | 415 Thousand USD | -99.88% |
| 2003 FY | 345.46 Million USD | -41.98% |
| 2003 Q4 | 345.46 Million USD | -41.98% |
| 2003 Q3 | 595.46 Million USD | 0.01% |
| 2003 Q2 | 595.41 Million USD | 0.05% |
| 2003 Q1 | 595.14 Million USD | -0.05% |
| 2002 Q1 | 251.42 Million USD | -0.18% |
| 2002 Q4 | 595.46 Million USD | 137.94% |
| 2002 Q3 | 250.26 Million USD | -0.29% |
| 2002 Q2 | 250.98 Million USD | -0.18% |
| 2002 FY | 595.46 Million USD | 136.41% |
| 2001 Q3 | 253.21 Million USD | -0.32% |
| 2001 Q1 | 254.79 Million USD | -0.19% |
| 2001 FY | 251.88 Million USD | -1.33% |
| 2001 Q4 | 251.88 Million USD | -0.53% |
| 2001 Q2 | 254.02 Million USD | -0.3% |
| 2000 Q4 | 255.27 Million USD | 4147.45% |
| 2000 Q2 | 86.26 Million USD | -0.88% |
| 2000 Q1 | 87.03 Million USD | -1.1% |
| 2000 FY | 255.27 Million USD | 190.08% |
| 2000 Q3 | 6.01 Million USD | -93.03% |
| 1999 Q3 | 96.2 Million USD | 9520.0% |
| 1999 Q2 | 1 Million USD | -16.67% |
| 1999 Q4 | 88 Million USD | -8.52% |
| 1999 Q1 | 1.2 Million USD | -14.29% |
| 1999 FY | 88 Million USD | 6185.71% |
| 1998 Q3 | 1.5 Million USD | -16.67% |
| 1998 Q2 | 1.8 Million USD | -28.0% |
| 1998 FY | 1.4 Million USD | -56.25% |
| 1998 Q4 | 1.4 Million USD | -6.67% |
| 1998 Q1 | 2.5 Million USD | -21.88% |
| 1997 Q2 | 4.9 Million USD | -14.04% |
| 1997 Q1 | 5.7 Million USD | -12.31% |
| 1997 FY | 3.2 Million USD | -50.77% |
| 1997 Q3 | 4 Million USD | -18.37% |
| 1997 Q4 | 3.2 Million USD | -20.0% |
| 1996 Q3 | 4.4 Million USD | -12.0% |
| 1996 Q4 | 6.5 Million USD | 47.73% |
| 1996 Q2 | 5 Million USD | -12.28% |
| 1996 Q1 | 5.7 Million USD | 0.0% |
| 1996 FY | 6.5 Million USD | 1.56% |
| 1995 Q3 | 7.1 Million USD | -8.97% |
| 1995 Q1 | 8.4 Million USD | -8.7% |
| 1995 Q2 | 7.8 Million USD | -7.14% |
| 1995 FY | 6.4 Million USD | 77.78% |
| 1994 Q1 | 3.6 Million USD | -2.7% |
| 1994 FY | 3.6 Million USD | 0.0% |
| 1994 Q4 | 9.2 Million USD | -2.13% |
| 1994 Q3 | 9.4 Million USD | -3.09% |
| 1994 Q2 | 9.7 Million USD | 169.44% |
| 1993 Q1 | 1.8 Million USD | 12.5% |
| 1993 Q2 | 2.1 Million USD | 16.67% |
| 1993 Q3 | 2.9 Million USD | 38.1% |
| 1993 Q4 | 3.7 Million USD | 27.59% |
| 1992 Q1 | 1 Million USD | 0.0% |
| 1992 Q3 | 1.5 Million USD | 36.36% |
| 1992 FY | 1.8 Million USD | 80.0% |
| 1992 Q4 | 1.6 Million USD | 6.67% |
| 1992 Q2 | 1.1 Million USD | 10.0% |
| 1991 Q1 | 800 Thousand USD | 0.0% |
| 1991 FY | 1 Million USD | 25.0% |
| 1990 FY | 800 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Amgen Inc. | 64.61 Billion USD | 61.328% |
| AstraZeneca PLC | 28.62 Billion USD | 12.7% |
| Biogen Inc. | 7.33 Billion USD | -240.506% |
| MIRA Pharmaceuticals, Inc. | 5061.00 USD | -493716556.787% |
| Scilex Holding Company | 128.46 Million USD | -19350.737% |
| Scilex Holding Company | 128.46 Million USD | -19350.737% |